Susquehanna Fundamental Investments, LLC Mersana Therapeutics, Inc. Transaction History
Susquehanna Fundamental Investments, LLC
- $2.14 Trillion
- Q1 2024
A detailed history of Susquehanna Fundamental Investments, LLC transactions in Mersana Therapeutics, Inc. stock. As of the latest transaction made, Susquehanna Fundamental Investments, LLC holds 234,116 shares of MRSN stock, worth $428,432. This represents 0.05% of its overall portfolio holdings.
Number of Shares
234,116Holding current value
$428,432% of portfolio
0.05%Shares
1 transactions
Others Institutions Holding MRSN
# of Institutions
128Shares Held
118MCall Options Held
68.1KPut Options Held
140K-
Eco R1 Capital, LLC San Francisco, CA19.4MShares$35.4 Million2.47% of portfolio
-
Vr Adviser, LLC New York, NY11.3MShares$20.7 Million4.36% of portfolio
-
Bain Capital Life Sciences Investors, LLC Boston, MA8.66MShares$15.9 Million5.86% of portfolio
-
Black Rock Inc. New York, NY8.1MShares$14.8 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.27MShares$11.5 Million0.0% of portfolio
About Mersana Therapeutics, Inc.
- Ticker MRSN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 97,169,296
- Market Cap $178M
- Description
- Mersana Therapeutics, Inc., a clinical stage biopharmaceutical company, develops antibody drug conjugates (ADC) for cancer patients with unmet need. It develops XMT-1592, a Dolasynthen ADC targeting NaPi2b-expressing tumor cells, which is in phase I clinical trial for the treatment of ovarian cancer and NSCLC adenocarcinoma. The company also dev...